Danyelza 40mg/10 mL (4 mg/mL) injection Images
Generic Name: naxitamab
This medication has been identified as Danyelza 40mg/10 mL (4 mg/mL) injection. It is supplied by Y-mAbs Therapeutics, Inc.
Danyelza is used in the treatment of Neuroblastoma and belongs to the drug class miscellaneous antineoplastics. Danyelza 40mg/10 mL (4 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Danyelza
- Generic Name
- naxitamab
- Strength
- 40mg/10 mL (4 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Y-mAbs Therapeutics, Inc.
- National Drug Code (NDC)
- 73042-0201
See also:
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Platinol
Platinol is used for bladder cancer, blood cell transplantation, bone marrow transplantation, brain ...
Oncovin
Oncovin is used for acute lymphocytic leukemia, acute myeloid leukemia, anaplastic ...
More about Danyelza (naxitamab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.